Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05169242 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
NotableStudy completion date changed from estimate of Dec 31, 2024 to Jul 29, 2025Trial status changed: Unknown → Completed · Primary completion date changed from estimate of Dec 14, 2024 to Jan 15, 2025 · Eligibility criteria expanded, about 13 words · 3 moreShow 6 more changesShow less
Trial status changed: Unknown → Completed
Primary completion date changed from estimate of Dec 14, 2024 to Jan 15, 2025
Eligibility criteria expanded, about 13 words
Secondary endpoints: details revised at 1 of 1 entry
Study description revised
Site details revised
MinorChangedRegistry marked status Unknown; last known: Recruiting
MinorTrial status: Recruiting to Unknownv4
NotablePrimary completion date: Dec 14, 2022 to Dec 14, 2024Completion date: Jun 14, 2023 to Dec 31, 2024 · Study description shortened, about 19 wordsv3Show 2 more changesShow less
NotableTrial status: Not Yet Recruiting to RecruitingStudy sites: 0 to 1v2Show 1 more changeShow less
Study sites: 0 to 1
MinorStudy First Submitted
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators hypothesize that prophylactic clipping after colonoscopic polypectomy can reduce risk of delayed PPB among DOAC users. The investigators also hypothesize that pre-endoscopy drug level can predict the risk of hemorrhagic complications after the procedure.